Results 81 to 90 of about 5,782,720 (331)

SPEMix: a lightweight method via superclass pseudo-label and efficient mixup for echocardiogram view classification

open access: yesFrontiers in Artificial Intelligence
IntroductionIn clinical, the echocardiogram is the most widely used for diagnosing heart diseases. Different heart diseases are diagnosed based on different views of the echocardiogram images, so efficient echocardiogram view classification can help ...
Shizhou Ma   +6 more
doaj   +1 more source

Classification Algorithm and Application Based on Semi-Supervised Deep Auto-Encoder Network [PDF]

open access: yesJisuanji gongcheng
In industrial classification prediction, labeled data are scarce, and labeling is expensive, leading to inaccurate model predictions. Simultaneously, features in most unlabeled data are not effectively used, resulting in insufficient generalization of ...
ZHANG Xinbo, ZHANG Xueying, HUANG Lixia, CHEN Guijun
doaj   +1 more source

Auto-Weighted Multi-View Learning for Image Clustering and Semi-Supervised Classification

open access: yesIEEE Transactions on Image Processing, 2018
Due to the efficiency of learning relationships and complex structures hidden in data, graph-oriented methods have been widely investigated and achieve promising performance.
F. Nie   +3 more
semanticscholar   +1 more source

JoshuaE1/supervised-classification-SSH-publications v1.0

open access: yes, 2020
A comparison of supervised machine learning ...
rafguns, JoshuaE1
core   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Supervised learning for document classification.

open access: yes, 2022
Supervised learning for document classification.
Magna Inácio (6141029)   +3 more
core   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

A Novel Object-Based Supervised Classification Method with Active Learning and Random Forest for PolSAR Imagery

open access: yesRemote Sensing, 2018
Most of the traditional supervised classification methods using full-polarimetric synthetic aperture radar (PolSAR) imagery are dependent on sufficient training samples, whereas the results of pixel-based supervised classification methods show a high ...
Wensong Liu   +5 more
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy